Is there any evidence that GLP-1 use in adolescents has adverse mental health outcomes?
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
There is limited evidence on the adverse mental health outcomes of GLP-1 receptor agonists in adolescents, and further study is needed to understand potential risks in this population.
Fields of Study & Subjects
Diabetes Treatment and Management
Pharmacology and Obesity Treatment
Diabetes Management and Research
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 March 2026
- Language
- EN